If unpredictable bloating, cramping, and bowel changes are running your life, you're not imagining it. A Texas physician explains modern, evidence-based IBS care.
By Dr. Casey Dean, DO · Board-Certified Family Medicine Physician (ABFM) · Published 2026-05-06
If you've been dealing with unpredictable bloating, cramping, diarrhea, constipation — or an exhausting cycle of all four — you're not imagining it, and you're far from alone. Irritable bowel syndrome (IBS) affects an estimated 7 to 16 percent of the U.S. population, making it one of the most common conditions seen in primary care. Yet despite its prevalence, IBS remains one of the most misunderstood and underdiagnosed digestive disorders in medicine. Many patients spend years bouncing between internet rabbit holes, elimination diets, and the quiet assumption that their symptoms are "just stress." They're not. IBS is a real, diagnosable medical condition — and modern medicine has more tools to manage it than most people realize.
IBS is classified as a disorder of gut-brain interaction (DGBI) — a condition where the communication between your brain and your digestive tract becomes disrupted. It is not inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It is not "all in your head." And it is not simply a food intolerance, though food can be a trigger.
According to the Rome IV diagnostic criteria — the current international standard used to diagnose functional gastrointestinal disorders — IBS is defined as recurrent abdominal pain occurring on average at least one day per week over the past three months, associated with two or more of the following: the pain is related to defecation, it's associated with a change in stool frequency, or it's associated with a change in stool form or appearance. Symptoms must have started at least six months before diagnosis.
IBS is a disorder of gut-brain interaction — there's no visible inflammation or tissue damage, and routine testing usually looks normal. IBD (Crohn's disease and ulcerative colitis) involves chronic inflammation and structural damage to the bowel wall and is diagnosed with imaging, endoscopy, and biopsies. IBS does not progress to IBD or increase your risk of colon cancer.
Usually not. The 2021 ACG guideline supports a positive diagnosis of IBS based on Rome IV symptom criteria and limited testing — not a full work-up to rule out everything else. A colonoscopy is reserved for patients with red-flag symptoms such as rectal bleeding, unintentional weight loss, nocturnal diarrhea, onset after age 50, or a family history of colorectal cancer or IBD.
Yes, for many patients. The low-FODMAP diet is the most studied dietary intervention for IBS and is recommended by the ACG. It works in three phases — elimination, reintroduction, and personalization — and is best done with the guidance of a registered dietitian to avoid unnecessary long-term restriction or nutritional gaps.
Low-dose tricyclic antidepressants like amitriptyline (10–30 mg at bedtime) are used in IBS as neuromodulators, not for mood. At these low doses, they reduce visceral hypersensitivity and recalibrate pain signaling in the gut-brain axis. Many patients with IBS notice meaningful improvement in pain and bowel symptoms within a few weeks.
Yes. IBS is well-suited to telehealth because it's a symptom-based diagnosis. At Trinity Family Medicine, a Texas-licensed, board-certified physician can review your symptoms, apply Rome IV criteria, screen for red flags, order targeted lab work (such as celiac serology), determine your IBS subtype, and build a personalized treatment plan starting at $49.99 — no insurance required.